精神分裂症中βIV血影蛋白的丰度、细胞分布及对AKT/GSK3调控的敏感性
精神分裂症(SCZ)生物学机制未明。该研究显示SCZ死后背外侧前额叶皮层神经元βIV血影蛋白水平低于健康对照(HC),PsychEncode数据集示SPTBN4与AKT2 mRNA升高且转录相关,体外验证两个GSK3磷酸化位点,iPSC神经元中βIV血影蛋白水平及对AKT/GSK3抑制剂敏感性改变,随机森林分类器分类准确率最高达98%。
要点
- SCZ死后背外侧前额叶皮层神经元βIV血影蛋白水平低于HC。
- PsychEncode数据示HC与SCZ中SPTBN4和AKT2 mRNA升高且基因转录相关。
- βIV血影蛋白影像随机森林分类器按诊断分类细胞准确率最高达98%。
核心结论
- SCZ中存在βIV血影蛋白水平改变及AKT/GSK3敏感性改变。
- βIV血影蛋白影像内表型被识别为稳健、可推广的SCZ预测生物标志物,具有可扩展临床应用的潜力。
研究设计与样本
- 研究分析SCZ死后样本(来自Human Brain Collection Core,HBCC)与健康对照(HC)的背外侧前额叶皮层神经元。
- 研究分析PsychEncode数据集,比较HC与SCZ的SPTBN4和AKT2 mRNA水平及基因转录相关性。
- 研究采用计算工具识别βIV血影蛋白上潜在AKT和GSK3磷酸化位点,并通过体外实验验证两个GSK3位点。
- 研究使用来自两个独立队列的iPSC衍生神经元,患者具有显著增加的家族遗传风险。
- 研究将随机森林分类器应用于βIV血影蛋白影像,在死后样本中按诊断分类细胞,在iPSC样本中按诊断或诊断×扰动分类细胞。
主要发现
- SCZ死后样本背外侧前额叶皮层神经元βIV血影蛋白蛋白水平低于HC(HBCC)。
- PsychEncode数据集中HC与SCZ均显示SPTBN4和AKT2 mRNA水平升高,且基因转录相关。
- 体外实验验证了βIV血影蛋白上的两个GSK3磷酸化位点。
- 两个独立iPSC队列中一致观察到βIV血影蛋白水平改变及对AKT/GSK3抑制剂敏感性改变。
- 随机森林分类器对βIV血影蛋白影像的分类准确率最高达98%,在死后样本中按诊断分类细胞,在iPSC样本中按诊断或诊断×扰动分类细胞。
关键数值与推荐
- 随机森林分类器应用于βIV血影蛋白影像,在死后样本中按诊断分类细胞准确率最高达98%。
- 随机森林分类器在iPSC样本中按诊断或诊断×扰动分类细胞准确率最高达98%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schizophrenia (SCZ) is a complex psychiatric disorder with unclear biological mechanisms. Spectrins, cytoskeletal proteins linked to neurodevelopmental disorders, are regulated by the AKT/GSK3 pathway, which is implicated in SCZ. However, the impact of SCZ-related dysregulation of this pathway on spectrin expression and distribution remains unexplored. Here, we show that βIV spectrin protein levels were reduced in neurons of the dorsolateral prefrontal cortex in SCZ postmortem samples compared to healthy control (HC) from the Human Brain Collection Core (HBCC). To investigate potential links between βIV spectrin and the AKT/GSK3 pathway, we analyzed the PsychEncode dataset, revealing elevated SPTBN4 and AKT2 mRNA levels with correlated gene transcription in both HCs and individuals with SCZ. Next, computational tools were employed to identify potential AKT and GSK3 phosphorylation sites on βIV spectrin, and two GSK3 sites were validated through in vitro assays. To assess whether βIV spectrin distribution and sensitivity to AKT/GSK3 are altered in SCZ, we used iPSC-derived neurons from two independent cohorts of patients with significantly increased familial genetic risk for the disorder. Alteration in βIV spectrin levels and sensitivity to AKT/GSK3 inhibitors were consistently observed across both cohorts. Importantly, a Random Forest classifier applied to βIV spectrin imaging achieved up to 98% accuracy in classifying cells by diagnosis in postmortem samples, and by diagnosis or diagnosis × perturbation in iPSC samples. These findings reveal altered βIV spectrin levels and AKT/GSK3 sensitivity in SCZ, identifying βIV spectrin image-based endophenotypes as robust, generalizable predictive biomarkers of SCZ, with the potential for scalable clinical applications.
引用
- Di Re J, Marini M, Hussain SI, et al. βIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophrenia. Mol Psychiatry. 2025. PMID: 39920295. doi:10.1038/s41380-025-02917-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。